The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 10, 2023
Filed:
Aug. 07, 2020
Suzhou Suncadia Biopharmaceuticals Co., Ltd., Jiangsu, CN;
Jiangsu Hengrui Medicine Co., Ltd., Jiangsu, CN;
Shanghai Hengrui Pharmaceutical Co., Ltd., Shanghai, CN;
Xiangdong Qu, Shanghai, CN;
Qiyue Hu, Shanghai, CN;
Shaoyu Xu, Shanghai, CN;
Dongbing Cui, Shanghai, CN;
Houcong Jin, Shanghai, CN;
Weikang Tao, Shanghai, CN;
Lianshan Zhang, Shanghai, CN;
Guoqing Cao, Shanghai, CN;
Piaoyang Sun, Jiangsu, CN;
Suzhou Suncadia Biopharmaceuticals Co., Ltd., Jiangsu, CN;
Jiangsu Hengrui Medicine Co., Ltd., Lianyungang, CN;
Shanghai Hengrui Pharmaceutical Co., Ltd., Shanghai, CN;
Abstract
The present invention relates to a PD-L1 antibody, antigen-binding fragments, and medical application thereof. Further, the present invention relates to chimeric antibodies and humanized antibodies comprising the CDR regions of the present PD-L1 antibody, as well as a pharmaceutical composition comprising the present PD-L1 antibody and the antigen-binding fragments thereof, and their use as anti-cancer drugs. In particular, the present invention relates to a humanized PD-L1 antibody and its use in preparation of a medicament for the treatment of PD-L1 mediated disease or disorder.